Cyclerion Shares to Watch With Deal in Focus as Markets Reopen
Cyclerion Therapeutics shares will trade on Nasdaq Tuesday with investors watching developments around its planned merger with Korsana Biosciences. There was no new company announcement. The stock finished Friday at $3.18, up 0.6%. Regular Nasdaq trading is set to start at 9:30 a.m. Eastern after Monday’s Memorial Day holiday. Korsana’s Alzheimer’s drug deal has turned Cyclerion into a backdoor public listing for the program. At Friday’s price, with 4.33 million shares showing in the recent quarterly, Cyclerion’s equity sits near $14 million. That leaves the company with limited cushion as it faces deal conditions like regulatory OKs, funding, and keeping its Nasdaq spot.